Drugs / Enoximone
Enoximone
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 33 trials | ||||||
| Phase 3 | NCT00348101 | Jun 2006 → May 2007 | coronary artery disorder | Klinikum Ludwigshafen | Completed | No outcome recorded |
| Phase 3 | NCT00077948 | Jul 2003 → Jun 2005 | congestive heart failure | Gilead Sciences | Terminated | No outcome recorded |
| Phase 3 | NCT00051285 | Feb 2002 → Jun 2005 | congestive heart failure | Gilead Sciences | Terminated | No outcome recorded |
| Phase 42 trials · 1 missed | ||||||
| Phase 4 | NCT04420455 | May 2020 → Dec 2021 | chronic obstructive pulmonary disease | Rijnstate Hospital | Terminated | No outcome recorded |
| Phase 4 | NCT00484133 | Jun 2007 → Dec 2008 | infectious disease with sepsis | Onze Lieve Vrouwe Gasthuis | Unknown | Missed primary |
| Comparator or background therapy1 trial | ||||||
| — | NCT05064202 Background | Oct 2023 → Oct 2027 expected | cardiogenic shock | Amsterdam UMC, location VUmc | Not yet recruiting | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | enoximone | “Enoximone, Dobutamine, Dopamine, Milrinone” NCT05064202 ↗ |
| Known as | Enoximona | ChEMBL registry synonym — accepted as the source's own label CHEMBL249856 ↗ |
| Known as | MDL 17,043 | ChEMBL registry synonym — accepted as the source's own label CHEMBL249856 ↗ |
| Known as | Perfan | ChEMBL registry synonym — accepted as the source's own label CHEMBL249856 ↗ |
| Action | Inhibit | “the PDE III inhibitor enoximone” PMID 19336536 ↗ Mar 2009 |
| Modality | Small molecule | — CHEMBL249856 ↗ |
| Route | Oral | “Participants receive oral enoximone” NCT00051285 ↗ |